Anti-metastatic potential is attributed to targeting ZEB1, ETS1 and FLT1 and EMT markers E-cadherin and vimentin by mir-200c,72 superoxide dismutase (MnSOD) targeting by mir-212 73 and Sox-4 targeting by mir-363-3p in CRC in tissue specimens, in vitro and in vivo.33 The gene discussed is VIM; the disease is colorectal carcinoma.